Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, February 11, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/s3bn4c/patch_pump_drug) has announced the addition of the "Patch Pump Drug Delivery Systems to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Devices, Drugs, Markets, and Forecasts
Patch pumps are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. The current generation of patch pumps focuses on insulin delivery, but a number of devices have been designed and are being developed to be - within the limits of drug pharmacology - essentially API agnostic. This report analyzes important therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
Key Topics Covered:
Chronic Conditions & Self-Administration
Demographics & Healthcare Economics
Generics and Branding
Patch Pump Device Strategies
Drug Delivery Mechanism
Sized Patch Pumps
Handheld Remote Electronics
Accuracy and Dosing Variability
Alerts and Patient Notification
FDA-Approved Patch Pump Devices
Non FDA-Approved Devices
Competing Patch Pump Devices
Trials & Approval
IP and Product Positioning
Sector Participant Company Profiles
For more information visit http://www.researchandmarkets.com/research/s3bn4c/patch_pump_drug
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.